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Introduction
Monogenic autoinflammatory diseases present with
overlapping clinical features such as recurrent fever, bio-
logical inflammation, abdominal pain, arthritis, and
sometimes disabling complications. Over 30 genes have
been confirmed or hypothesized as causing diseases.
Sanger sequencing is the gold-standard approach for
genetic diagnosis, but cannot be exhaustive.
Objectives
We aimed at offering a quick and efficient service for
these genetically heterogeneous disorders through NGS
sequencing of all published and candidate (N=32) auto-
inflammatory genes.
Patients and methods
34 patients were selected on clinical grounds by members
of the French reference center for autoinflammatory dis-
eases (CeReMAI). 9 of them were considered positive
control samples as they had previously known variants
(by Sanger sequencing) and were run in parallel for
methodological validation.
A custom panel of 108kb was designed to capture the
genomic regions of interest using the Illumina Nextera
Rapid Capture enrichment DNA preparation kit. MicroV2
chip were then loaded with 12 samples on a MiSeq equip-
ment for multiparallel sequencing. Annotation and filter-
ing were performed with Seqnext software (JSI), and
annotation was performed with Alamut Visual (Interactive
Biosoftware).
Results
We obtained a 545X average coverage and only 2
exons were not captured. Minimal coverage was 40X.
Results were concordant in 100% of the cases with
Sanger analysis. We uncovered pathological mutations
or variants of unknown significance in 17 patients. Of
note recurrent genes were CARD14, NOD2, PSTPIP1
and SCL29A3. About 20 new potentially pathogenic
sequence variants were found in published genes.
Conclusion
This innovative sequencing approach demonstrated high
performance (accuracy, the precision, analytical sensitiv-
ity and specificity) in evaluating mutations in known
autoinflammatory genes. The current positive rate using
sequential Sanger sequencing of 1-4 genes in the French
network is quite stable around 10-15%. The NGS
approach allowed diagnosis of approximately another
20% of patients.
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